Llwytho...
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780
Alzheimer's disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid Aβ1-42, in the brain. Aβ1-42 levels can be decreased by γ-secretase modulators (GSM), which are small molecules that modulate γ-secretase, an...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Hindawi Publishing Corporation
2014
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4109680/ https://ncbi.nlm.nih.gov/pubmed/25097793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/431858 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|